Molecular epidemiology of hepatitis B and C virus infections in Asia

Tran T T Huy1, Kenji Abe

  • 1Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.

Insights

Molecular epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) in Asia reveals genotype-specific disease severity and treatment responses. Understanding these viral factors is crucial for managing liver diseases and hepatocellular carcinoma in endemic regions.

Area of Science:

  • Hepatology
  • Virology
  • Molecular Epidemiology

Background:

  • Hepatitis B virus (HBV) and hepatitis C virus (HCV) are major causes of blood-borne infectious diseases globally.
  • These viruses are particularly prevalent in Asia, leading to acute and chronic liver diseases, including liver cancer.
  • Genotypic variations in HBV and HCV influence disease progression and treatment outcomes.

Purpose of the Study:

  • To review the molecular epidemiology of HBV and HCV, focusing on Asia.
  • To examine the relationship between viral genotypes, pathogenicity, and therapeutic sensitivity.
  • To highlight the significance of HBV/HCV genotypes in liver disease and hepatocellular carcinoma.

Main Methods:

  • Literature review of molecular-based epidemiology studies.
  • Analysis of HBV and HCV genotype distributions and their geographic relevance.
  • Examination of HBV mutants and HCV genotypes in relation to disease severity and treatment.

Main Results:

  • HBV genotypes B and C are prevalent in Asia, with genotype C associated with more severe liver disease.
  • Specific HBV mutants (pre-S, basal core promoter, YMDD, vaccine escape) are common in Asia and linked to disease severity and therapy response.
  • HCV genotype 1 shows reduced sensitivity to interferon therapy and may cause more severe disease.

Conclusions:

  • HBV and HCV genotypes play a significant role in the pathogenicity of chronic liver diseases and hepatocellular carcinoma.
  • Understanding genotype-specific characteristics is vital for effective therapeutic strategies in endemic regions like Asia.
  • Further research is needed to elucidate the complex interplay between HBV/HCV genotypes, disease progression, and treatment efficacy.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...